LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,439 | +346.1% | 6,762 | +368.9% | 0.00% | – |
| Q2 2023 | $5,927 | +29535.0% | 1,442 | -85.5% | 0.00% | -100.0% |
| Q1 2023 | $20 | +33.3% | 9,972 | +108.4% | 0.00% | 0.0% |
| Q4 2022 | $15 | -99.9% | 4,786 | +37.1% | 0.00% | – |
| Q3 2022 | $17,000 | +240.0% | 3,490 | +291.7% | 0.00% | – |
| Q2 2022 | $5,000 | -89.4% | 891 | -91.6% | 0.00% | -100.0% |
| Q4 2021 | $47,000 | +23.7% | 10,655 | +151.6% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | +245.5% | 4,235 | +203.1% | 0.00% | – |
| Q2 2021 | $11,000 | -15.4% | 1,397 | +33.0% | 0.00% | – |
| Q1 2021 | $13,000 | -38.1% | 1,050 | -44.3% | 0.00% | -100.0% |
| Q4 2020 | $21,000 | -54.3% | 1,885 | -53.8% | 0.00% | 0.0% |
| Q3 2020 | $46,000 | +411.1% | 4,080 | +407.5% | 0.00% | – |
| Q2 2020 | $9,000 | – | 804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |